COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 1576: Articles 15751-15760  | Next

Protocol of the COVID-19 Health Adherence Research in Scotland Vaccination (CHARIS-V) study: Understanding the influence of vaccination decisions on adherence to transmission-reducing behaviours in a prospective longitudinal study of the Scottish Population.
Maciver, M., Den Daas, C., Johnston, M., Dixon, D., Hubbard, G.
10.1101/2021.05.03.21256503 — Posted: 2021-05-05
ROCCA study protocol and interim analysis on safety of Sputnik V vaccine (Gam-COVID-Vac) in the Republic of San Marino: an observational study using active surveillance
Montalti, M., Solda, G., Di Valerio, Z., Salussolia, A., Lenzi, J., Forcellini, M., Barvas, E., Guttmann, S., Messina, R., Poluzzi, E., Raschi, E., Riccardi, R., Fantini, M. P., La Fauci, G., Gori, D., San Marino Republic COVID ROCCA Group
10.1101/2021.05.03.21256509 — Posted: 2021-05-05
Male-Female Disparities in Years of Potential Life Lost Attributable to COVID-19 in the United States: A State-by-State Analysis
Xu, J. J., Chen, J. T., Belin, T. R., Brookmeyer, R. S., Suchard, M. A., Ramirez, C. M.
10.1101/2021.05.02.21256495 — Posted: 2021-05-05
Comprehensive mapping of neutralizing antibodies against SARS-CoV-2 variants induced by natural infection or vaccination
Chen, X., Chen, Z., Azman, A. S., Sun, R., Lu, W., Zheng, N., Zhou, J., Wu, Q., Deng, X., Zhao, Z., Chen, X., Ge, S., Yang, J., Leung, D. T., Yu, H.
10.1101/2021.05.03.21256506 — Posted: 2021-05-05
Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis
Goubet, A.-G., DUBUISSON, A., GERAUD, A., DANLOS, F.-X., TERRISSE, S., ALVES COSTA SILVA, C., DRUBAY, D., TOURI, L., PICARD, M., MAZZENGA, M., SILVIN, A., DUNSMORE, G., HADDAD, Y., PIZZATO, E., LY, P., FLAMENT, C., MELENOTTE, C., SOLARY, E., FONTENAY, M., GARCIA, G., BALLEYGUIER, C., LASSAU, N., MAEURER, M., PIACENTINI, M., GRAJEDA-IGLESIAS, C., NIRMALATHASAN, N., APRAHAMIAN, F., DURAND, S., KEPP, O., FERRERE, G., THELEMAQUE, C., LAHMAR, I., FAHRNER, J.-E., MEZIANI, L., AHMED-BELKACEM, A., SAIDANI, N., LA SCOLA, B., RAOULT, D., GENTILE, S., CORTAREDONA, S., IPPOLITO, G., LELOUVIER, B., ROULET, A., ANDRE, F., BARLESI, F., SORIA, J.-C., PRADON, C., GALLOIS, E., POMMERET, F., COLOMBA, E., GINHOUX, F., KAZANDJIAN, S., ELKRIEF, A., ROUTY, B., MIYARA, M., GOROCHOV, G., DEUTSCH, E., ALBIGES, L., STOCLIN, A., GACHOT, B., FLORIN, A., MERAD, M., SCOTTE, F., ASSAAD, S., KROEMER, G., BLAY, J.-Y., MARABELLE, A., GRISCELLI, F., Zitvogel, L., DEROSA, L.
10.1101/2021.04.26.21250357 — Posted: 2021-05-05
Changes in work and health of Australians during the COVID-19 pandemic: a longitudinal cohort study
Griffiths, D., Sheehan, L., van Vreden, C., Petrie, D., Whiteford, P., Sim, M., Collie, A.
10.1101/2021.05.02.21256492 — Posted: 2021-05-05
Preventing COVID-19 Outbreaks Through Surveillance Testing in Healthcare Facilities - A Modelling Study
Litwin, T., Timmer, J., Berger, M., Wahl-Kordon, A., Mueller, M., Kreutz, C.
10.1101/2021.05.03.21255976 — Posted: 2021-05-05
Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a phase 1, dose-escalating, randomised controlled study
Khoo, S. H., FitzGerald, R., Fletcher, T., Ewings, S., Jaki, T., Lyon, R., Downs, N., Walker, L., Tansley-Hancock, O., Greenhalf, W., Woods, C., Reynolds, H., Marwood, E., Mozgunov, P., Adams, E., Bullock, K., Holman, W., Bula, M. D., Gibney, J. L., Saunders, G., Corkhill, A., Hale, C., Thorne, K., Chiong, J., Condie, S., Pertinez, H., Painter, W., Wrixon, E., Johnson, L., Yeats, S., Mallard, K., Radford, M., Fines, K., Shaw, V., Owen, A., Lalloo, D. G., Jacobs, M., Griffiths, G.
10.1101/2021.05.03.21256309 — Posted: 2021-05-05
Serological Response in Lung Transplant Recipients after Two Doses of SARS-CoV-2 mRNA Vaccines
Narasimhan, M., Mahimainathan, L., Clark, A. E., Usmani, A., Cao, J., Raj, E., Torres, F., Sarode, R., Kaza, V., Lacelle, C., Muthukumar, A.
10.1101/2021.04.26.21255926 — Posted: 2021-05-05
Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient: a source of immune escape variants
Weigang, S., Fuchs, J., Zimmer, G., Schnepf, D., Kern, L., Beer, J., Luxenburger, H., Ankerhold, J., Falcone, V., Kemming, J., Hofmann, M., Thimme, R., Neumann-Haefelin, C., Ulferts, S., Grosse, R., Hornuss, D., Tanriver, Y., Rieg, S., Wagner, D., Huzly, D., Schwemmle, M., Panning, M., Kochs, G.
10.1101/2021.04.30.21256244 — Posted: 2021-05-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).